Answers are grounded in this paper and cite their sources.
This study investigates the structural stability, luminescence response, morphology, and in vitro cytocompatibility of Pr3+-doped fluorapatite (PrFAPk) nanocrystals calcined at 1000 °C, focusing on the relationship between rare-earth incorporation and high-temperature thermal treatment. X-ray diffraction confirmed the retention of the hexagonal fluorapatite structure (P63/m) without secondary crystalline phases, accompanied by a unit-cell volume expansion and a decrease in crystallite size from 109 to 58 nm with increasing Pr3+ content. Rietveld refinement indicated that Pr3+ ions occupy both crystallographically distinct Ca sites with preferential association, while hydroxyl oxygen partially substitutes fluorine positions in the channels. FTIR and FIR spectroscopy verified the preservation of the principal phosphate framework alongside local F–OH environment modifications. SEM-EDS revealed agglomerated morphologies with a homogeneous Pr distribution, and DLS showed nanoscale hydrodynamic populations alongside larger aggregates. Photoluminescence and MCR-ALS analyses demonstrated dominant host-lattice emission coupled with Pr3+-related features, reflecting thermally induced changes in the local emitting environment. MTT assays using MG-63 osteoblast-like cells showed cell viability above 80% across concentrations of 25–100 µg/mL after 24–72 h, with Pr-doped samples exhibiting favorable cytocompatibility responses. Overall, the results demonstrate that Pr3+ incorporation is compatible with fluorapatite framework preservation during high-temperature consolidation, offering promising potential for multifunctional ceramic biomaterials.
No takes yet. Share an insight, caveat, or question.
Milojkov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: